Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Recruiting · NCT06732388 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus | Barrett esophagus, Digestive System Diseases, digestive system disorder, esophageal adenocarcinoma, esophageal disorder, neoplasm, precancerous condition | Recruiting | Phase 2 | 2026-09-14 | NCT06732388 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor University Medical Center | Dallas | United States | 87 |
| Case Western Reserve University | Cleveland | United States | 219 |
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 243 |
| University of Kansas Cancer Center | Kansas City | United States | 242 |
| University of Michigan Rogel Cancer Center | Ann Arbor | United States | 186 |
| Washington University School of Medicine | St Louis | United States | 895 |